Novanta NOVT Medical Solutions — Goodwill Impaired Accumulated Impairment Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.
The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novanta's medical solutions — goodwill impaired accumulated impairment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novanta's medical solutions — goodwill impaired accumulated impairment loss?
- Novanta (NOVT) reported medical solutions — goodwill impaired accumulated impairment loss of $31.72M in Q1 2026.
- How has Novanta's medical solutions — goodwill impaired accumulated impairment loss changed year-over-year?
- Novanta's medical solutions — goodwill impaired accumulated impairment loss decreased by 0.0% year-over-year, from $31.72M to $31.72M.
- What is the long-term trend for Novanta's medical solutions — goodwill impaired accumulated impairment loss?
- Over 2 years (2023 to 2025), Novanta's medical solutions — goodwill impaired accumulated impairment loss has grown at a 0.0% compound annual growth rate (CAGR), from $126.89M to $126.89M.
- What does medical solutions — goodwill impaired accumulated impairment loss mean?
- The cumulative amount of impairment charges recognized against goodwill specifically allocated to the Medical Solutions segment. This metric indicates the historical erosion of value from past acquisitions due to underperformance or changes in market conditions.